Ruane, Cunniff & Goldfarb L.P. Elevance Health, Inc. Transaction History

Ruane, Cunniff & Goldfarb L.P.

$5.3 Billion
Q3 2025

A detailed history of Ruane, Cunniff & Goldfarb L.P. transactions in Elevance Health, Inc. stock. As of the latest transaction made, Ruane, Cunniff & Goldfarb L.P. holds 1,448,283 shares of ELV stock, worth $472 Million. This represents 8.82% of its overall portfolio holdings.

Number of Shares

1,448,283

Previous 1,095,655 32.18%

Holding current value

$472 Million

Previous $426 Million 9.81%

% of portfolio

8.82%

Previous 8.56%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$274.66 - $395.76 $96.9 Million - $140 Million	352,628 Added 32.18%	1,448,283 $468 Million
Q2 2025 Aug 13, 2025	SELL	$372.27 - $452.69 $10.1 Million - $12.3 Million	-27,265 Reduced 2.43%	1,095,655 $426 Million
Q1 2025 May 14, 2025	SELL	$365.9 - $436.25 $7.7 Million - $9.18 Million	-21,033 Reduced 1.84%	1,122,920 $488 Million
Q4 2024 Feb 13, 2025	BUY	$365.96 - $514.62 $51 Million - $71.7 Million	139,420 Added 13.88%	1,143,953 $423 Million
Q3 2024 Nov 13, 2024	SELL	$500.12 - $562.29 $9.77 Million - $11 Million	-19,538 Reduced 1.91%	1,004,533 $522 Million
Q2 2024 Aug 13, 2024	SELL	$497.49 - $547.8 $25.2 Million - $27.7 Million	-50,614 Reduced 4.71%	1,024,071 $555 Million
Q1 2024 May 14, 2024	SELL	$464.61 - $519.96 $35.1 Million - $39.3 Million	-75,536 Reduced 6.57%	1,074,685 $557 Million
Q3 2023 Nov 13, 2023	BUY	$414.13 - $475.93 $42.1 Million - $48.3 Million	101,573 Added 9.69%	1,150,221 $501 Million
Q2 2023 Aug 11, 2023	BUY	$436.33 - $496.2 $105 Million - $120 Million	241,524 Added 29.92%	1,048,648 $466 Million
Q1 2023 May 12, 2023	SELL	$446.3 - $502.2 $8.66 Million - $9.74 Million	-19,399 Reduced 2.35%	807,124 $371 Million
Q4 2022 Feb 13, 2023	SELL	$465.23 - $546.77 $75.1 Million - $88.2 Million	-161,334 Reduced 16.33%	826,523 $424 Million
Q3 2022 Nov 14, 2022	SELL	$445.98 - $507.0 $11.7 Million - $13.2 Million	-26,130 Reduced 2.58%	987,857 $449 Million
Q2 2022 Aug 15, 2022	SELL	$444.32 - $529.84 $330 Million - $394 Million	-743,441 Reduced 42.3%	1,013,987 $489 Million
Q1 2022 May 13, 2022	SELL	$428.44 - $502.48 $5.4 Million - $6.34 Million	-12,612 Reduced 0.71%	1,757,428 $863 Million
Q4 2021 Feb 14, 2022	SELL	$370.08 - $467.67 $19 Million - $24 Million	-51,373 Reduced 2.82%	1,770,040 $820 Million
Q3 2021 Nov 15, 2021	SELL	$357.51 - $398.13 $8.08 Million - $8.99 Million	-22,588 Reduced 1.22%	1,821,413 $679 Million
Q2 2021 Aug 16, 2021	BUY	$352.19 - $401.9 $237 Million - $270 Million	672,156 Added 57.36%	1,844,001 $704 Million
Q1 2021 May 17, 2021	BUY	$287.7 - $371.31 $337 Million - $435 Million	1,171,845 New	1,171,845 $421 Million

Others Institutions Holding ELV

# of Institutions

1,784

Shares Held

200M

Call Options Held

2.52M

Put Options Held

2.23M

View Full List

About Elevance Health, Inc.

Ticker ELV
Exchange NYSE
Sector Healthcare
Industry Healthcare Plans
Shares Outstandng 240,000,992
Market Cap $78.2B
Description
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....

More about ELV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ruane, Cunniff & Goldfarb L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ruane, Cunniff & Goldfarb L.P. with notifications on news.

Account

Ruane, Cunniff & Goldfarb L.P. Elevance Health, Inc. Transaction History